-
Why SOD Activity Matters in Redox Translation
2026-09-10
A mechanistic and strategic guide to using the Superoxide Dismutase Activity Assay Kit in oxidative stress research, with practical lessons from known ROS measurement confounders and guidance for translational study design.
-
γH2AX in FLASH Radiotherapy: From Signal to Strategy
2026-09-09
A translational framework for using the γH2AX DNA Damage Detection Kit to connect double-strand break biology with radiosensitizer evaluation, FLASH radiotherapy design, and preclinical decision-making.
-
Cannabidiol, Orofacial Pain, and Affective Circuits
2026-09-09
This 2026 Brain Research Bulletin study shows that cannabidiol reduces both inflammatory orofacial nociception and pain-related affective and cognitive deficits in mice. Its combined behavioral, molecular, endocannabinoid, and serotonergic analyses provide a framework for separating peripheral analgesia from central emotional effects and for designing receptor-level follow-up studies.
-
SERCA-Mediated ER Stress in HSC Mobilization
2026-09-08
Li et al. identify SERCA-mediated endoplasmic reticulum stress as a regulator of hematopoietic stem cell mobilization. Their in vivo and molecular data connect SERCA inhibition by BHQ to the CaMKII-STAT3-CXCR4 axis, offering a mechanistic framework for improving stem cell collection while highlighting the need for careful calcium and stress-response control.
-
E. coli Uracil-DNA Glycosylase (UDG) Protocol
2026-09-08
E. coli Uracil-DNA Glycosylase (UDG), SKU K1107, removes uracil residues from single- and double-stranded DNA to support PCR product contamination elimination and related DNA repair enzyme workflows. It should be used for research DNA workflows, not RNA substrates, oligonucleotides shorter than six bases, or diagnostic and medical applications.
-
GLT-1-CB1 Signaling in TBI Cognitive Dysfunction
2026-09-07
A 2025 Biomolecules study identifies an astrocyte-centered mechanism linking elevated 2-AG, CB1 activation, reduced CREB phosphorylation, and loss of GLT-1 after traumatic brain injury. In mice, pharmacological CB1 blockade with AM 281 restored GLT-1-associated glutamate control, reduced neuronal apoptosis, and improved behavioral measures of cognitive function.
-
ERADECs for Targeted Degradation of TM Proteins
2026-09-05
Song et al. establish ERAD-engaging chimeras (ERADECs), a small-molecule platform that redirects ER-associated degradation toward transmembrane proteins. Their PD-L1 studies and mutant HTT findings show how a desonide-based ER E3-ligase recruiter can address limitations of conventional targeted protein degradation.
-
RP3-340N1.2–IL-6 Axis in NSCLC
2026-09-05
The reference study identifies RP3-340N1.2 as an oncogenic long non-coding RNA that promotes non-small cell lung cancer progression by preserving IL-6 mRNA through interaction with the RNA-binding protein ZC3H12A. Its combined tumor-cell and macrophage experiments connect post-transcriptional RNA control with the tumor microenvironment, offering a useful framework for cancer research and RNA metabolism studies.
-
γH2AX DNA Damage Detection Kit: Assay Logic
2026-09-04
The γH2AX DNA Damage Detection Kit (Mouse mAb/Red) converts DNA double-strand break biology into a spatial, image-based readout. This guide connects γ-H2AX interpretation with FLASH radiotherapy and EGCG nanoparticle studies while emphasizing controls, timing, and assay limitations.
-
ERADECs Enable ERAD-Based Membrane Protein Degradation
2026-09-04
Song et al. establish ERAD-engaging chimeras (ERADECs), a small-molecule platform that redirects transmembrane proteins to the ER-associated degradation pathway. By using desonide to recruit the ER E3 ligase SYVN1, the study achieves potent PD-L1 degradation and demonstrates a broader route for eliminating otherwise difficult membrane-associated targets.
-
ERADECs: ERAD-Hijacking for Membrane Protein Degradation
2026-09-03
Song et al. establish ERAD-engaging chimeras (ERADECs), a small-molecule targeted protein degradation platform that redirects transmembrane proteins to the ER-associated degradation pathway. By using desonide to engage the ER E3 ligase SYVN1, the study achieves potent PD-L1 degradation and demonstrates a broader strategy for membrane-protein and mutant HTT research.
-
EDC.HCl: Practical Coupling Workflow
2026-09-03
EDC.HCl is a water-soluble carbodiimide used to activate carboxyl groups for amide bond formation with primary amines in peptide synthesis, bioconjugation, and related in vitro workflows. It is a laboratory reagent rather than an in vivo or clinical product because the supplied dossier reports no in vivo or clinical data.
-
Mitomycin C: DNA Lesions to Assay Design
2026-09-02
Mitomycin C is an antitumor antibiotic whose DNA-adduct chemistry can be used to interrogate replication stress, apoptosis signaling research, and DNA-repair dependency. This guide translates ERCC1–p53 findings into practical assay-design decisions for cancer research and combination studies.
-
Triamcinolone Protocol and QC Guide
2026-09-02
Triamcinolone is a synthetic glucocorticoid agonist for controlled in vitro studies of glucocorticoid signaling, inflammation, and immunosuppression. This guide addresses stock preparation, solvent controls, storage, assay setup, and QC while defining why the compound should not be used for diagnostic, therapeutic, or clinical applications.
-
SERCA-ER Stress Drives HSC Mobilization
2026-09-01
Li, Xu, and Huang show that pharmacological SERCA inhibition with BHQ enhances hematopoietic stem cell mobilization in mice through a CaMKII–STAT3–CXCR4 mechanism. The study links controlled calcium-store perturbation and mild endoplasmic reticulum stress to reduced surface CXCR4, providing a mechanistic framework for improving stem-cell collection while highlighting the need for further translational validation.